March 29, 2012
Takeda Pharmaceutical announced on March 28 that the US FDA approved on March 27 Omontys (peginesatide), a treatment for renal anemia jointly developed by Takeda and Affymax, Inc. of the US, for anemia due to chronic kidney disease (CKD) in...read more